Ohio Pharmacy CE Requirement 40-Hour Package
Included Courses
Courses included in this package. Click on a course to learn more.
- Addiction Medicine Part 2: Alcohol 2Course Release Date: 10/21/22
Alcohol use disorder is a serious national health problem in the United States. It is estimated that more than 14 million American adults had an alcohol use disorder in 2019, as well as 414,000 adolescents aged 12 to 17. There is a clear need for improvement in the treatment of alcohol use disorder; this course serves to review the recognition, diagnosis, and treatment of alcohol use disorder and alcohol withdrawal.
- Clinical Management of Substance Use Disorders 5
Course release date: 7/10/2023
About the Course
Substance use and abuse cost society more than $740 billion annually in workplace productivity, healthcare, and crime-related expenses (NIDA, 2020). Substance use disorders are complex phenomena affecting individuals' and families’ lives. This course reviews common substance use disorders, including alcohol, anxiolytics, stimulants, hallucinogens, and tobacco/vaping. The course also examines federal and state-controlled substance regulations and the prescribing practices for controlled substances. The focus is on clinical and safety considerations by nurse practitioners when prescribing non-cancer-related opioid medications for acute/chronic pain. - Educating Patients: Creating Teaching Moments in Practice 4Course release date: 12/21/2022
About the Course
Effective education is essential to help patients and family gain knowledge. All healthcare professionals (HCPs) can identify teaching opportunities to assess and provide effective education. The purpose of this course is to provide HCPs with current evidence-based information to help them learn and apply skills and practice for effective patient and family teaching in a variety of settings. - Heart Failure: Evidence Review and Management 2Release Date: 8/10/2022
About the Course
Heart failure is a complex clinical syndrome associated with increasing morbidity, mortality, and economic burden. Despite evidence supporting guideline-directed therapy and management for reduction of morbidity and mortality, these medications are still underprescribed. According to the CHAMP-HF registry, among eligible patients, only 22% were prescribed essential heart failure medications per guideline recommendations ((Greene et al., 2018). Healthcare providers have an essential role in improving outcomes with heart failure by bridging the gap between guideline-directed recommendations and actual clinical practice. The learning outcomes of this activity will help clinicians understand this healthcare gap by reviewing the current evidence-based pharmacotherapy recommendations for HF treatment through analyzing clinical trials and guidelines.
- Pain Management: Evidence-Based Guidance for Prescribing Opioids 5
Course release date: 6/12/2023
About the Course
This course will provide a general review of federal and state-controlled substance regulations and the prescribing practices for controlled substances, including drug diversion. However, the focus is on clinical safety considerations when prescribing non-cancer-related opioid medications for acute/chronic pain in adults.
- Patient Safety and Medication Errors for Pharmacy Professionals 2
Course Release: 4/1/2024
About the course
This educational program is designed to accomplish at least two important goals: first to provide examples of critical potential medication errors, and secondly to offer mechanisms that pharmacy professionals can take to intervene in these mishaps and enhance patient care. In addition to offering these critical examples and potential solutions, two case studies are included to help put some of the ideas into realistic scenarios similar to those that may be encountered in contemporary pharmacy practice. Evidence-based practice information from current peer-reviewed literature is also included for context and ideas for pharmacists to consider in efforts to improve their practice appear throughout the program. Lastly, a post-test is included at the end of the program to test your understanding of the material.
- Pharmacotherapy to Assist with Smoking Cessation 3Release Date: 1/26/2021
About the Course:
After completing this course, pharmacists will be able to help select first-line pharmacotherapy to assist smokers in quitting, educate smokers on potential adverse effects of these pharmacotherapies, and provide counseling that includes how and when to properly take the medication - Pharmacy Law: Federal Regulations & HIPAA 4
Course release date: 8/9/2024
About the Course
Pharmacy is, by far, the most regulated profession in health care. Pharmacists have a professional obligation to stay current in their knowledge of laws and regulations and their implications to practice and patient care. Federal drug legislation has distinguished between prescription and over-the-counter medications and established that drugs must be both safe and effective, must be properly labeled, and must be manufactured and stored under sanitary conditions. In addition, the Controlled Substances Act (CSA) has expanded regulatory oversight and scheduling of medications to minimize diversion, misuse, and abuse. Federal legislation has been enacted to combat methamphetamine abuse, deter tampering with medications, ensure patient privacy, and mandate patient counseling. It is important to understand the scope of laws and regulations so that we can practice in accordance. Federal and state laws are meant to operate concurrently. If one law is more strict, that is the law we must follow as pharmacists.
- Prescribing Strategies for Older Adults 3
Course release date: 10/09/2023
About the Course
This course will explore the intricacies of pharmacological principles and their profound impact on choosing the perfect medications enhancing the learners' ability to effectively apply pharmacologic principles to the medication selection process for the older adult. It will examine the age-related changes influencing medication effectiveness and adverse drug effects. The course addresses the challenges and complexities of medication management in the aging population, considering factors such as disease burdens, cognitive and organ system decline, and social determinants of health.
- The Complications of Chronic Kidney Disease, Second Edition 2
Release Date: 7/10/2023
About the Course:
This course serves as a review of chronic kidney disease (CKD) and the medications used to prevent adverse effects of CKD and slow disease progression. - The Pharmacist's Role in the Opioid Crisis, 2nd Edition 6
Course Release: 1/9/2024
About the course
This course will provide pharmacists practicing in healthcare systems and community pharmacy settings an overview of contemporary considerations for ways that the opioid crisis intersects with pharmacy practice. This course will provide pharmacists with a history of the current state of the opioid crisis and how pharmacy practice has expanded to meet patient and community needs as well as ethical dimensions of the opioid crisis and the role of social determinants of health in opioid-related disparities. This course will provide pharmacists with an understanding of the disease state of opioid use disorder and how opioids affect the brain, how the pharmacist can be supportive of patients with opioid use disorder to reduce stigma and facilitate treatment-seeking, and the benefits of medications for opioid use disorder; participants will review the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain (2022 Clinical Practice Guideline).
- The Pharmacologic Management of Anxiety in Adults 2Release Date: 7/10/2023About the CourseAnxiety disorders are the most commonly diagnosed psychiatric disorders, with an estimated 264 million persons globally suffering from an anxiety disorder. It’s estimated that 19.1% of adults in the United States (U.S.) are affected by at least one anxiety disorder; this number increases to 31.9% in U.S. adolescents. Common anxiety disorders include generalized anxiety disorder (GAD), panic disorder (PD), specific phobias, agoraphobia, social anxiety disorder (SAD), and separation anxiety disorder. This course reviews the diagnosis and pharmacological management of anxiety disorders, as well as medications which can cause or exacerbate anxiety symptoms.